The company has reported a net profit of Rs 41.43 crore in same period last year.
Total income for the quarter ended June 30, stood at Rs 683.07 crore. Inspite of the increase in volumes by about 14 per cent on year-on-year basis, the fall in RM prices, trailing lower crude prices, resulted into reduction of total income, a company statement said.
EBITDA (earnings before interest, tax, depreciation and amortisation) for the quarter stood at Rs 131.91 crore compared with Rs 113.09 crore in the first quarter of FY15, an increase of 16.6 per cent year-on-year.
The recently concluded USFDA inspection had been favourable for the company. This would facilitate and expedite faster approvals for various APIs in pipeline, thereby increasing the presence in the regulated markets, it added.
Consistent year-on-year growth in the speciality chemical segment with commissioning of various facilities and faster paced growth in pharma segment, along with favourable USFDA inspection report would help maintain the growth momentum, it said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
